Evidence map›Paper›PMID 19597705›Full record

ArticleBreast cancer research and treatment2010

Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence.

Lyndsay V Rhodes, Shannon E Muir, Steven Elliott, Lori M Guillot, James W Antoon, Patrice Penfornis, Syreeta L Tilghman, Virgilio A Salvo, Juan P Fonseca, Michelle R Lacey and 5 more

Open access · greenAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment.Journal of mammary gland biology and neoplasia · 2021
    Review
  12. LncRNAs link cancer stemness to therapy resistance.American journal of cancer research · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Lyndsay V RhodesDepartment of Medicine, Section of Hematology & Medical Oncology, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.
Shannon E Muir
Steven Elliott
Lori M Guillot
James W Antoon
Patrice Penfornis
Syreeta L Tilghman
Virgilio A Salvo
Juan P Fonseca
Michelle R Lacey
Barbara S Beckman
John A McLachlan
Brian G Rowan
Radhika Pochampally
Matthew E Burow
Tulane University · US

Funding

miRNA-mediated Stromal Cell Survival under Stress Supports Breast Cancer GrowthR01CA151851 · NCI · UNIVERSITY OF MISSISSIPPI MED CTR · PI POCHAMPALLY, RADHIKA R · 2011 to 2016
$1.5M
NCI NIH HHS R01 CA151851
6 · The paper itself

Abstract

Adult human mesenchymal stem cells (hMSCs) have been shown to home to sites of breast cancer and integrate into the tumor stroma. We demonstrate here the effect of hMSCs on primary breast tumor growth and the progression of these tumors to hormone independence. Co-injection of bone marrow-derived hMSCs enhances primary tumor growth of the estrogen receptor-positive, hormone-dependent breast carcinoma cell line MCF-7 in the presence or absence of estrogen in SCID/beige mice. We also show hormone-independent growth of MCF-7 cells when co-injected with hMSCs. These effects were found in conjunction with increased immunohistochemical staining of the progesterone receptor in the MCF-7/hMSC tumors as compared to MCF-7 control tumors. This increase in PgR expression indicates a link between MCF-7 cells and MSCs through ER-mediated signaling. Taken together, our data reveal the relationship between tumor microenvironment and tumor growth and the progression to hormone independence. This tumor stroma-cell interaction may provide a novel target for the treatment of estrogen receptor-positive, hormone-independent, and endocrine-resistant breast carcinoma.

Indexed as

AnimalsAntineoplastic Agents, HormonalCell Line, TumorDisease ProgressionDrug Resistance, NeoplasmFemaleHumansImmunohistochemistryMammary Neoplasms, ExperimentalMesenchymal Stem CellsMiceMice, SCIDReceptors, EstrogenReceptors, ProgesteroneXenograft Model Antitumor AssaysAntineoplastic Agents, HormonalReceptors, EstrogenReceptors, Progesterone

Identifiers

PMID19597705
PMCPMC4943323
OpenAlexW2065801888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.